+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Halitosis Market- Growth, Trends, Covid-19 Impact, And Forecasts (2022 - 2027)

  • PDF Icon


  • 111 Pages
  • June 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 5617258
The Halitosis market is projected to register a CAGR of 12.5% during the forecast period (2022 - 2027).

At the beginning of COVID‐19 pandemic, clinician thought oral involvement is not a COVID‐19 presentation. However, recently SARS‐CoV‐2 has been isolated from saliva of infected patients and was determined reverse transcriptase‐polymerase chain reaction (RT‐PCR) test from saliva even could be a more sensitive than nasopharyngeal sampling.

As with other circulating pandemics, halitosis has been greatly challenged by the outbreak of the coronavirus disease (COVID-19), and a few confirmed cases were reported to present with halitosis while being actively infected. According to a letter in Special Care in Dentistry in November 2020, the SARS-CoV-2 virus can cause changes to the surface of the tongue and the chemicals in saliva. These changes may lead to the development of halitosis (bad breath). In addition to this, Bad breath is also a common side effect of several over-the-counter medicines used to treat COVID-19 at home. Thus, the pandemic has increased the demand for oral hygiene and various products, thereby impacting the market growth.

The factors propelling the growth of the market are the rising prevalence of periodontal diseases, increasing consumption of alcohol and tobacco, medical condition such as tonsils, and inflammation of nose, throat or sinuses are major factors expected to drive growth of the global halitosis treatment market over the forecast period. As per the study published by Dovepress in 2021, the prevalence of oral halitosis was 44.2% among the study participants. Rural residency, low monthly income, poor tooth-brushing habit, smoking, and dental caries were independent factors of halitosis. Moreover, as per the study published by Australian Dental Journal in 2020, 90% of halitosis cases the source of the malodour is the oral cavity. With the increaseing prevalence of Halitosis globally, is a major factor which is expected to drive the Halitosis market’s growth during the forecast period.

Furthermore, Persistent bad breath or a bad taste in the mouth may be a warning sign of gum (periodontal) disease. As per the Centers of Disease Control and Prevention, 2020, 47.2% of adults aged 30 years and older have some form of periodontal disease in the United States.

In addition, rising occurrence of halitosis along with increasing awareness regarding diseases among people coupled with increasing spending on treatments are other factors expected to further fuel growth of the target market over the forecast period.

Key Market Trends

Liver Disorders Segment is Expected to Hold a Major Market Share in the Halitosis Market

Although 90% of halitosis is intra-oral, it is still important to consider potential extra-oral systemic causes. For instance as per the study published by the Australian Dental Journal in 2020, the liver is one of the most important extra-oral sources of bad breath, with its chronic infection affecting approximately 400 million people around the world. The term fetor hepaticus, referring to a slightly sweet, musty and faecal breath is directly correlated with hepatitis and liver failure.

According to a study published by National Library of Medicine in 2020, an estimated 1.5 billion persons have chronic liver disease worldwide and the age-standardized incidence of chronic liver disese and cirrhosis is 20.7/100,000, a 13% increase since 2000. Similarly, cirrhosis prevalence and mortality has increased in recent years in the United States. With the increase in liver diseases cases there is an increase in the people suffering from bad breath and hence, the Halitosis market is expected to show an increase in the forecast period.

Thus, due to the above-mentioned reasons, the market is expected to witness significant growth over the forecast period.

North America is Expected to Dominate the Market Over the Forecast Period

North America is one of the major contributors in the studied market owing to, rising awareness among population regarding the disease, availability of its treatment is in the region, increasing prevalence of halitosis and increasing chronic diseases in the region.

As per North Ajax Dental, An estimated sixty-five percent of Americans have bad breath. Over forty-million Americans have "chronic halitosis," which is persistent bad breath. Ninety percent of all halitosis is of oral, not systemic, origin. Americans spend more than USD 1 billion a year on over the counter halitosis products, many of which are ineffective because they only mask the problem.

The prevalence of periodontal (gum) disease continues to be an important public health problem in the United States as 2 in 5 adults are affected by some form of this disease. Increasing consumption of tobacco and alcohol is the major factor causing halitosis. Tobacco products and increase risk of gum disease can also cause bad breath. As per the Bad Breath Institute, It is estimated that over 25% of the population regularly suffer from bad breath, regardless of gender, age or social class, and that 50% of individuals have at some point been concerned about their breath. Therefore, owing to these factors, the United States is believed to have a significant share in the market studied over the forecast period among all the other countries in the region.

Competitive Landscape

The Halitosis market is fragmented competitive and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Dabur India, Colgate Palmolive, Johnson & Johnson, P&G, Oracare, Dentsply Sirona, Dentaid SL, Church & Dwight, Cipla, Rowpar Pharmaceuticals and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Prevalence of Periodontal Diseases
4.2.2 Availability of Wide Range of Products
4.3 Market Restraints
4.3.1 Lack of Awareness About Halitosis and its Treatment
4.3.2 Alternative Treatment
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Type
5.1.1 Pathological
5.1.2 Non-pathological
5.2 By Treatment
5.2.1 Antacids
5.2.2 Antiseptics
5.2.3 Antiplaque
5.2.4 Others
5.3 By Diagnostic Test
5.3.1 Halimeter
5.3.2 Gas chromatography
5.3.3 BANA test
5.3.4 ß-galactosidase activity assay
5.3.5 Other Tests
5.4 By Indication
5.4.1 Respiratory Disorders
5.4.2 Liver Disorders
5.4.3 Gestrointestinal Disorders
5.4.4 Kidney Disorders
5.4.5 Others
5.5 By Geography
5.5.1 North America United States Canada Mexico
5.5.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.5.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.5.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.5.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Dabur India
6.1.2 Colgate Palmolive
6.1.3 Johnson&Johnson
6.1.4 P&G
6.1.5 Oracare
6.1.6 Dentsply Sirona
6.1.7 Dentaid SL
6.1.8 Church & Dwight
6.1.9 Cipla
6.1.10 Rowpar Pharmaceuticals

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Dabur India
  • Colgate Palmolive
  • Johnson&Johnson
  • P&G
  • Oracare
  • Dentsply Sirona
  • Dentaid SL
  • Church & Dwight
  • Cipla
  • Rowpar Pharmaceuticals